RESCUE and REVERSE Long-term Follow-up



Status:Recruiting
Conditions:Ocular, Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:15 - Any
Updated:4/17/2018
Start Date:January 9, 2018
End Date:August 2022
Contact:Barrett Katz, MD
Email:bkatz@gensight-biologics.com
Phone:+1-646-831-3799

Use our guide to learn which trials are right for you!

Long-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular Gene Therapy in the RESCUE or REVERSE Phase III Clinical Trials

The goal of this clinical trial is to assess the long-term safety and efficacy of GS010, a
gene therapy, and assess the quality of life in subjects with LHON due to the G11778A ND4
mitochondrial mutation and who were treated in the Rescue or Reverse studies.


Inclusion Criteria Subjects must meet all the following criteria at Inclusion period to be
eligible for inclusion.

- Subject was treated with GS010 IVT injection in either of the RESCUE or REVERSE Phase
III clinical studies

- Subject of legal consent age has provided informed consent; subjects that are not of
legal consent age have undergone their country-approved clinical trial enrollment
consent process

Non-Inclusion Criteria Subjects meeting any of the following criteria at Inclusion period
will be excluded from eligibility.

- Subject is unwilling or unable to comply with the protocol requirements

- Subject has any medical or psychological condition that, in the opinion of the
Investigator, may compromise his or her safe participation in the study

- Subject is taking or intending to take idebenone during the long-term follow-up study
period
We found this trial at
4
sites
28 Rue de Charenton
Paris, 75012
Principal Investigator: Catherine Vignal-Clermont, MD
?
mi
from
Paris,
Click here to add this to my saved trials
1364 Clifton Rd NE
Atlanta, Georgia 30322
(404) 712-2000
Principal Investigator: Nancy Newman, MD
Emory University Hospital As the largest health care system in Georgia and the only health...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pasadena, California 91105
Principal Investigator: Alfredo Sadun, MD
?
mi
from
Pasadena, CA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19107
Principal Investigator: Mark Moster, MD
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials